| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |